Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir

By Calza Leonardo   Trapani Filippo   Salvadori Caterina   Magistrelli Eleonora   Manfredi Roberto   Colangeli Vincenzo   Di Bari Maria Assunta   Borderi Marco   Viale Pierluigi  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 2, 2013-02 ,pp. : 147-154

Informa Healthcare

Access to resources Recommend Favorite

Tenofovir-induced Fanconi syndrome and osteomalacia in two HIV-infected patients: Role of intracellular tenofovir diphosphate levels and review of the literature

By Haverkort Milly E.   van der Spek Bas W.   Lips Paul   Slieker Walentina A.   ter Heine Rob   Huitema Alwin D.   Bronsveld Willem  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 10, 2011-10 ,pp. : 821-826

Informa Healthcare

Access to resources Recommend Favorite

Nephrotoxicity Associated with Antiretroviral Therapy in HIV-Infected Patients

By  

Current Drug Safety, Vol. 2, Iss. 2, 2007-05 ,pp. : 147-154

Bentham Science Publishers

Access to resources Recommend Favorite

Tenofovir treatment in an unselected cohort of highly antiretroviral experienced HIV positive patients

By Lerbæk Anne   Kristiansen Thomas   Katzenstein Terese   Mathiesen Lars   Gerstoft Jan   Nielsen Claus   Larsen Klaus   Nielsen Jens   Obel Niels   Laursen Alex   Nielsen Susanne  

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 4, 2004-04 ,pp. : 280-286

Informa Healthcare

Access to resources Recommend Favorite

Osteoporosis in HIV-infected patients

By Groger Richard   Quirk Erin   Powderly William  

Clinical Review in Bone and Mineral Metabolism, Vol. 2, Iss. 2, 2004-06 ,pp. : 167-173

Humana Press, Inc

Access to resources Recommend Favorite